Literature DB >> 22610928

HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals.

Sylvie Lang1, Murielle Mary-Krause, Anne Simon, Marialuisa Partisani, Jacques Gilquin, Laurent Cotte, Franck Boccara, Dominique Costagliola.   

Abstract

BACKGROUND: Individuals infected by human immunodeficiency virus (HIV) have a higher risk of cardiovascular disease than the general population. The specific effects of virological and immunological parameters on the risk of myocardial infarction (MI) in HIV-infected individuals are debated.
METHODS: We conducted a nested case-control study within the French Hospital Database on HIV. Case patients (n = 289) were patients who, between January 2000 and December 2006, had a prospectively recorded and validated first MI. Up to 5 HIV-infected controls (n = 884) matched for age, sex, and clinical center were selected, at random with replacement, among patients with no history of MI. Conditional logistic regression models were used to identify predictors of the risk of MI.
RESULTS: Plasma HIV-1 RNA levels >50 copies/mL, a low CD4 T-cell nadir, and a high CD8 T-cell count were independently associated with an increased risk of MI, with respective odds ratios of 1.51 (95% confidence interval, 1.09-2.10), 0.90 (.83-.97) per log(2) unit, and 1.48 (1.01-2.18) for the highest tertile of CD8 T-cell counts (>1150 cells/mm(3)) compared with the lowest (≤760 cells/mm(3)).
CONCLUSIONS: Independently of cardiovascular risk factors and antiretroviral therapy, HIV replication, a low CD4 T-cell nadir and a high current CD8 T-cell count are associated with an increased risk of MI in HIV-infected individuals. This suggests new paths for interventions to diminish the risk of MI in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610928     DOI: 10.1093/cid/cis489

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  56 in total

1.  Editorial Commentary: Clinical management of cardiovascular disease in HIV-infected patients.

Authors:  Alison Kearns; Tricia H Burdo; Xuebin Qin
Journal:  Trends Cardiovasc Med       Date:  2017-07-22       Impact factor: 6.677

Review 2.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 3.  Inflammation, immune activation, and cardiovascular disease in HIV.

Authors:  Eric Nou; Janet Lo; Steven K Grinspoon
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

Review 4.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

Review 5.  Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.

Authors:  John Charles A Lacson; Revery P Barnes; Hossein Bahrami
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

6.  Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data From the Veterans Aging Cohort Study.

Authors:  Brittanny M Polanka; Suman Kundu; Kaku A So-Armah; Matthew S Freiberg; Samir K Gupta; Roger J Bedimo; Matthew J Budoff; Adeel A Butt; Chung-Chou H Chang; Stephen S Gottlieb; Vincent C Marconi; Julie A Womack; Jesse C Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2019-05-01       Impact factor: 3.731

Review 7.  Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?

Authors:  Shima Shahbaz; Marcella Manicardi; Giovanni Guaraldi; Paolo Raggi
Journal:  World J Cardiol       Date:  2015-10-26

8.  CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy.

Authors:  Jessica L Castilho; Bryan E Shepherd; John Koethe; Megan Turner; Sally Bebawy; James Logan; William B Rogers; Stephen Raffanti; Timothy R Sterling
Journal:  AIDS       Date:  2016-03-27       Impact factor: 4.177

9.  Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Authors:  Margalida Rotger; Tracy R Glass; Thomas Junier; Jens Lundgren; James D Neaton; Estella S Poloni; Angélique B van 't Wout; Rubin Lubomirov; Sara Colombo; Raquel Martinez; Andri Rauch; Huldrych F Günthard; Jacqueline Neuhaus; Deborah Wentworth; Danielle van Manen; Luuk A Gras; Hanneke Schuitemaker; Laura Albini; Carlo Torti; Lisa P Jacobson; Xiuhong Li; Lawrence A Kingsley; Federica Carli; Giovanni Guaraldi; Emily S Ford; Irini Sereti; Colleen Hadigan; Esteban Martinez; Mireia Arnedo; Lander Egaña-Gorroño; Jose M Gatell; Matthew Law; Courtney Bendall; Kathy Petoumenos; Jürgen Rockstroh; Jan-Christian Wasmuth; Kabeya Kabamba; Marc Delforge; Stephane De Wit; Florian Berger; Stefan Mauss; Mariana de Paz Sierra; Marcelo Losso; Waldo H Belloso; Maria Leyes; Antoni Campins; Annalisa Mondi; Andrea De Luca; Ignacio Bernardino; Mónica Barriuso-Iglesias; Ana Torrecilla-Rodriguez; Juan Gonzalez-Garcia; José R Arribas; Iuri Fanti; Silvia Gel; Jordi Puig; Eugenia Negredo; Mar Gutierrez; Pere Domingo; Julia Fischer; Gerd Fätkenheuer; Carlos Alonso-Villaverde; Alan Macken; James Woo; Tara McGinty; Patrick Mallon; Alexandra Mangili; Sally Skinner; Christine A Wanke; Peter Reiss; Rainer Weber; Heiner C Bucher; Jacques Fellay; Amalio Telenti; Philip E Tarr
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

Review 10.  Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.

Authors:  Emma Kaplan-Lewis; Judith A Aberg; Mikyung Lee
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.